Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA070172-02
Application #
2114117
Study Section
Special Emphasis Panel (NSS)
Project Start
1995-08-01
Project End
1999-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Radiation-Diagnostic/Oncology
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Chen, Lei L; Chen, Xinjian; Choi, Haesun et al. (2012) Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother 61:1113-24
Blanke, Charles D; Rankin, Cathryn; Demetri, George D et al. (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626-32
Heinrich, Michael C; Owzar, Kouros; Corless, Christopher L et al. (2008) Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Gr J Clin Oncol 26:5360-7
Chen, Lei L; Holden, Joseph A; Choi, Haesun et al. (2008) Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21:826-36
Choi, Haesun; Charnsangavej, Chuslip; Faria, Silvana C et al. (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753-9
Benjamin, Robert S; Choi, Haesun; Macapinlac, Homer A et al. (2007) We should desist using RECIST, at least in GIST. J Clin Oncol 25:1760-4
Beinart, Garth A; Gonzalez-Angulo, Ana M; Broglio, Kristine et al. (2007) Phase II trial of 10-EDAM in the treatment of metastatic breast cancer. Cancer Chemother Pharmacol 60:61-7
Chen, Lei L; Sabripour, Mahyar; Andtbacka, Robert H I et al. (2005) Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep 7:293-9
Chen, Lei L; Sabripour, Mahyar; Wu, Elsie F et al. (2005) A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene 24:4271-80
Choi, Haesun; Charnsangavej, Chuslip; de Castro Faria, Silvana et al. (2004) CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183:1619-28

Showing the most recent 10 out of 19 publications